Can India end child labour

2016/01/01 by Matthew J. Samec, Jigisha Rakholiya, Hannah Langenfeld +15 · 1 citation
Medicine · Social Sciences · #Otitis Media and Relapsing Polychondritis #Poverty, Education, and Child Welfare #Systemic Sclerosis and Related Diseases #Vasculitis and related conditions

paper · pdf · doi:10.3899/jrheum.2022-1214

openalex publication_date 2016/01/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/01

Abstract

TCZ is well tolerated in GCA, with low rates of discontinuation for AESIs. However, relapse occurred in > 50% despite median treatment > 12 months. Since the duration of TCZ prior to discontinuation did not significantly affect subsequent risk of GCA recurrence, further research is needed to determine the optimal duration of therapy.

Citations

• The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
• 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Cited by

• Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee

Related

• Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
• Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database
• Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
• A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
• Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysis